Free Shipping Worldwide

Secure Payment

Toei Shinyaku Presented King Agaricus KA21 Research at the 26th Annual Meeting of the Japanese Society of Men's Health

Toei Shinyaku Presented King Agaricus KA21 Research at the 26th Annual Meeting of the Japanese Society of Men's Health

Posted on September 28 2026, By: MotoiAkitomo

Toei Shinyaku Presented King Agaricus KA21 Research at the 26th Annual Meeting of the Japanese Society of Men's Health

Toei Shinyaku Co., Ltd. gave an oral presentation at the 26th Annual Meeting of the Japanese Society of Men's Health, held September 26–27, 2026 at KDDI Ishin Hall in Yamaguchi, Japan. The study examined the effects of King Agaricus KA21 (outdoor-cultivated Agaricus brasiliensis KA21) on male menopausal symptoms, sexual function and stress-related indicators in middle-aged and older men. We also exhibited at the meeting.

Presentation Details

  • Conference: The 26th Annual Meeting of the Japanese Society of Men's Health (September 26–27, 2026, KDDI Ishin Hall, Yamaguchi, Japan)
  • Title: Effects of Outdoor-Cultivated Agaricus brasiliensis KA21 on Male Menopausal Symptoms, Sexual Function and Stress-Related Indicators in Middle-Aged and Older Men
  • Presentation No.: GO3-1, General Oral Session 3 / LOH (Treatment)
  • Date and time: Sunday, September 27, 2026, 9:10–10:00 a.m.
  • Authors: Akitomo Motoi (Toei Shinyaku Co., Ltd.), Yuki Ishida, Masahiro Takeda (Raika Co., Ltd.), Yuichiro Suzuki (D Clinic Shinjuku), Hoichi Amano (eHealth Clinic Shinjuku), Rina Motoi (Toei Shinyaku Co., Ltd.), Hirobumi Tada (Shigakkan University)

Study Overview

King Agaricus KA21 is rich in beta-glucan and vitamin D, and has been reported in human clinical trials to reduce fatigue and improve hair loss. This study examined the effects of continuous intake of King Agaricus KA21 on male menopausal symptoms (Aging Males' Symptoms [AMS] scale), sexual function and stress-related indicators in men aged 40 and older.

  • Design: Randomized, double-blind, placebo-controlled crossover study
  • Participants: 15 men aged 40 years or older
  • Intake: King Agaricus KA21 (800 mg/day) or placebo for 8 weeks each, with a 2-month washout period between the two phases
  • Measures: AMS scale (with subgroup analysis by severity: mild, moderate and severe) and blood cortisol

Key Findings

  • In the severe AMS group, sexual function-related items improved significantly with King Agaricus KA21 intake (p < 0.05).
  • In the severe and moderate AMS groups, morning erections improved significantly with King Agaricus KA21 intake (p < 0.01).
  • Worsening of "depressed mood," an indicator of mental state, was suppressed (p < 0.05).
  • Blood cortisol decreased significantly with King Agaricus KA21 intake (p < 0.05).

These results suggest that continuous intake of King Agaricus KA21 may help improve sexual function-related items in men with moderate or higher AMS scores, and may be useful for maintaining and improving QOL characteristic of middle-aged and older men. The decrease in cortisol suggests that an improved stress response may be involved in its action.

Background

Late-onset hypogonadism (LOH), also known as male menopause, can affect vitality, sexual function and overall quality of life in middle-aged and older men. Toei Shinyaku holds a Japanese patent on the use of King Agaricus KA21 for improving male menopausal symptoms, including erectile dysfunction and decreased libido, based on a human clinical trial. Results from the same study were also presented at the 36th Annual Meeting of the Japanese Society for Sexual Medicine on September 19, 2026.